<PAGE>   1
                                                                    EXHIBIT 99.2





                               LIGGETT GROUP INC.

                        CONSOLIDATED FINANCIAL STATEMENTS


                                 MARCH 31, 1999












<PAGE>   2



                               LIGGETT GROUP INC.

                                    Index to
                              Financial Statements

<TABLE>
<CAPTION>


                                                                                                          Page
                                                                                                          ----


    <S>                                                                                                    <C>
    Consolidated Balance Sheets as of March 31, 1999 and December 31, 1998...................               2
    Consolidated Statements of Operations for the three months ended March 31, 1999
         and 1998............................................................................               4
    Consolidated Statement of Stockholder's Equity (Deficit) for the three months
         ended March 31, 1999................................................................               5
    Consolidated Statements of Cash Flows for the three months ended March 31, 1999
         and 1998............................................................................               6
    Notes to Consolidated Financial Statements...............................................               7

</TABLE>








<PAGE>   3



                               LIGGETT GROUP INC.

                           CONSOLIDATED BALANCE SHEETS

                (Dollars in thousands, except per share amounts)


<TABLE>
<CAPTION>

                                                                          March 31,      December 31,
                                                                            1999            1998
                                                                          ---------      ------------

                                     ASSETS
<S>                                                                       <C>            <C>
Current assets:
     Accounts receivable:
         Trade, less allowances of $1,685 and $1,686,                                              
         respectively ............................................        $  14,940      $   14,510
         Other ...................................................              824             821

     Inventories .................................................           27,963          25,974

     Other current assets ........................................            4,514          10,561
                                                                          ---------      ----------

             Total current assets ................................           48,241          51,866

Property, plant and equipment, at cost, less accumulated
    depreciation of $31,663 and $30,893, respectively ............           21,707          16,195

Intangible assets, at cost, less accumulated amortization
    of $20,554 and $20,550, respectively .........................              167             171

Other assets .....................................................            6,885           6,491
                                                                          ---------      ----------

              Total assets .......................................        $  77,000      $   74,723
                                                                          =========      ==========
</TABLE>





                   The accompanying notes are an integral part
                         of these financial statements.

                                       2
<PAGE>   4


                               LIGGETT GROUP INC.

                     CONSOLIDATED BALANCE SHEETS (Continued)

                (Dollars in thousands, except per share amounts)

<TABLE>
<CAPTION>


                                                                                     March 31,         December 31,
                                                                                        1999               1998
                                                                                     ---------         ------------
                 LIABILITIES AND STOCKHOLDER'S EQUITY (DEFICIT)

<S>                                                                                  <C>               <C>
Current liabilities:
     Current maturity of note payable .......................................        $     329         $      --
     Cash overdraft .........................................................               43                63
     Accounts payable, principally trade ....................................            2,870             3,206
     Accrued expenses:
        Promotional .........................................................           22,117            23,760
        Income taxes ........................................................            1,062               115
        Other taxes, principally excise taxes ...............................            3,352             3,397
        Estimated allowance for sales returns ...............................            7,100             7,100
        Interest ............................................................               11                12
        Settlement accruals .................................................            1,235             1,120
        Proceeds received for options .......................................          150,000           150,000
        Other ...............................................................            9,459            10,697
                                                                                     ---------         ---------

            Total current liabilities .......................................          197,578           199,470

Credit facility and note payable, less current maturities ...................           10,939             2,538

Non-current employee benefits ...............................................           10,755            10,902

Other long-term liabilities .................................................            7,441             6,999

Commitments and contingencies (Note 7)

Stockholder's equity (deficit):
     Redeemable preferred stock (par value $1.00 per share; authorized 1,000
       shares; no shares issued and outstanding)
     Common stock (par value $0.10 per share; authorized 2,000 shares; issued
       and outstanding 1,000 shares)
       and contributed capital ..............................................           57,870            57,380
     Accumulated deficit ....................................................         (207,583)         (202,566)
                                                                                     ---------         ---------

             Total stockholder's equity (deficit)  ..........................         (149,713)         (145,186)
                                                                                     ---------         ---------

             Total liabilities and stockholder's equity (deficit)  ..........        $  77,000         $  74,723
                                                                                     =========         =========
</TABLE>


                   The accompanying notes are an integral part
                         of these financial statements.

                                       3
<PAGE>   5



                               LIGGETT GROUP INC.

                      CONSOLIDATED STATEMENTS OF OPERATIONS

                             (Dollars in thousands)



<TABLE>
<CAPTION>

                                                                                    Three Months Ended
                                                                                         March 31,
                                                                                         ---------
                                                                                   1999             1998
                                                                                   ----             ----

<S>                                                                              <C>              <C>
Net sales*  .............................................................        $ 86,047         $ 65,626

Cost of sales* ..........................................................          23,165           26,221
                                                                                 --------         --------

          Gross profit ..................................................          62,882           39,405

Selling, general and administrative expenses ............................          42,813           33,154
                                                                                 --------         --------

          Operating income ..............................................          20,069            6,251

Other income (expense):
     Interest expense ...................................................            (707)          (7,083)
     Other, net .........................................................             (47)             368
                                                                                 --------         --------

           Income (loss) before income taxes ............................          19,315             (464)

Income tax provision ....................................................           7,632               --
                                                                                 --------         --------

          Net income (loss) .............................................        $ 11,683         $   (464)
                                                                                 ========         ========
</TABLE>




*Net sales and cost of sales include federal excise taxes of $12,553 and
$14,809, respectively.


                   The accompanying notes are an integral part
                         of these financial statements.

                                       4
<PAGE>   6



                               LIGGETT GROUP INC.

            CONSOLIDATED STATEMENT OF STOCKHOLDER'S EQUITY (DEFICIT)

                             (Dollars in thousands)

<TABLE>
<CAPTION>

                                                           Common                             Total
                                                          Stock and                       Stockholder's
                                                         Contributed                         Equity
                                                           Capital          Deficit         (Deficit)
                                                           -------          -------         ---------

<S>                                                        <C>            <C>               <C>
Balance at December 31, 1998 ......................        $57,380        $(202,566)        $(145,186)

   Net income .....................................             --           11,683            11,683
   Accretion of capital contribution ..............            490               --               490
   Distributions and other payments ...............             --          (16,700)          (16,700)
                                                           -------        ---------         ---------

Balance at March 31, 1999  ........................        $57,870        $(207,583)        $(149,713)
                                                           =======        =========         =========

</TABLE>




                   The accompanying notes are an integral part
                         of these financial statements.

                                       5
<PAGE>   7


                               LIGGETT GROUP INC.

                      CONSOLIDATED STATEMENTS OF CASH FLOWS

                             (Dollars in thousands)
<TABLE>
<CAPTION>

                                                                                   Three Months Ended
                                                                                        March 31,
                                                                                        ---------

                                                                                   1999             1998
                                                                                 --------         --------

<S>                                                                              <C>              <C>
Cash flows from operating activities ....................................        $ 14,346         $ (5,579)
                                                                                 --------         --------

Cash flows from investing activities:
    Proceeds from sale of property, plant and equipment .................              13              702
    Capital expenditures ................................................          (6,369)            (353)
                                                                                 --------         --------
            Net cash (used in) provided by investing activities .........          (6,356)             349
                                                                                 --------         --------


Cash flows from financing activities:
    Repayments of note ..................................................             (25)              21
    Issuance of note ....................................................           4,500               --
    Borrowings under revolving credit facility ..........................          75,574           62,692
    Repayments under revolving credit facility ..........................         (71,319)         (57,492)
    Deferred finance charges ............................................              --              (38)
    Distributions and other payments to affiliates ......................         (16,700)              --
    (Decrease) increase in cash overdraft ...............................             (20)              47
                                                                                 --------         --------
            Net cash (used in) provided by financing activities .........          (7,990)           5,230
                                                                                 --------         --------


Net increase in cash and cash equivalents ...............................              --               --
Cash and cash equivalents:
    Beginning of period .................................................              --               --
                                                                                 --------         --------
    End of period .......................................................        $    -0-         $    -0-
                                                                                 ========         ========
</TABLE>

                   The accompanying notes are an integral part
                         of these financial statements.

                                       6
<PAGE>   8


                               LIGGETT GROUP INC.

                   Notes to Consolidated Financial Statements

                (Dollars in thousands, except per share amounts)


1.       THE COMPANY

Liggett Group Inc. ("Liggett" or the "Company") is a wholly-owned subsidiary of
BGLS Inc. ("BGLS"), a wholly-owned subsidiary of Brooke Group Ltd. ("BGL").
Liggett is engaged primarily in the manufacture and sale of cigarettes,
principally in the United States. Certain management and administrative
functions are performed by affiliates. (See Note 8.)

The interim consolidated financial statements included herein are unaudited and,
in the opinion of management, reflect all adjustments necessary (which are
normal and recurring) to present fairly the Company's consolidated financial
position, results of operations and cash flows. The December 31, 1998 balance
sheet has been derived from audited financial statements. These consolidated
financial statements should be read in conjunction with the consolidated
financial statements and the notes thereto included as Exhibit 99.2 in Brooke's
and BGLS' Annual Report on Form 10-K, as amended, for the year ended December
31, 1998, as filed with the Securities and Exchange Commission. The consolidated
results of operations for interim periods should not be regarded as necessarily
indicative of the results that may be expected for the entire year.

All of the Company's common shares (1,000 shares, issued and outstanding for all
periods presented herein) are owned by BGLS. Accordingly, earnings and dividends
per share data are not presented in these consolidated financial statements.


2.       ESTIMATES AND ASSUMPTIONS

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities, the disclosure of
contingent assets and liabilities and the reported amounts of revenues and
expenses. Significant estimates subject to material changes in the near term
include allowance for doubtful accounts, sales returns and allowances, actuarial
assumptions of pension plans and litigation and defense costs. Actual results
could differ from those estimates.


3.       PHILIP MORRIS BRAND TRANSACTIONS

         On November 20, 1998, Liggett and BGL entered into a definitive
agreement with Philip Morris Incorporated ("PM") which provided for PM to
purchase options in an entity which will hold three cigarette brands, L&M,
Chesterfield and Lark (the "Marks"), held by Liggett's subsidiary Eve. As
contemplated by the agreement, Liggett and PM entered into additional agreements
(collectively, the "PM Agreements") on January 12, 1999 to effectuate the
transactions.

         Under the terms of the PM Agreements, Eve will contribute the Marks to
Brands LLC ("LLC"), a newly-formed limited liability company, in exchange for
100% of two classes of LLC interests, the Class A Voting Interest (the "Class A
Interest") and the Class B Redeemable Nonvoting Interest (the "Class B
Interest"). PM acquired two options to purchase such interests (the "Class A
Option" and the "Class B Option"). On December 2, 1998, PM paid Eve a total of
$150,000 for such options, $5,000 for the Class A Option and $145,000 for the
Class B Option. The payments were used to fund the redemption of the


                                       7
<PAGE>   9

11.5% Senior Secured Notes due February 1, 1999 and the Variable Rate Series C
Senior Secured Notes due February 1, 1999 (together, the "Liggett Notes")
together with accrued interest on December 28, 1998.

The Class A Option entitles PM to purchase the Class A Interest for $10,100. The
statutory waiting period under the Hart-Scott-Rodino Act regarding the exercise
by PM of the Class A Option expired on February 12, 1999. On March 19, 1999, PM
exercised the Class A Option with the closing scheduled for no later than June
10, 1999 (currently scheduled to close May 24, 1999), subject to customary
closing conditions.

The Class B Option will entitle PM to purchase the Class B Interest for
$139,900. The Class B Option will be exercisable during the 90-day period
beginning on December 2, 2008, with PM being entitled to extend the 90-day
period for up to an additional six months under certain circumstances. The Class
B Interest will also be redeemable by the LLC for $139,900 during the same
period the Class B Option may be exercised.

The LLC will seek to borrow $134,900 (the "Loan") from a lending institution.
The Loan will be guaranteed by Eve and collateralized by a pledge by the LLC of
the Marks and of the LLC's interest in the trademark license agreement
(discussed below) and by a pledge by Eve of its Class B Interest. In connection
with the closing of the Class A Option, the LLC will distribute the Loan
proceeds to Eve with respect to its Class B Interest. The cash exercise price of
the Class B Option and the LLC's redemption price will be reduced by the amount
distributed to Eve. Upon PM's exercise of the Class B Option or the LLC's
exercise of its redemption right, PM or the LLC, as relevant, will be required
to procure Eve's release from its guaranty. The Class B Interest will be
entitled to a guaranteed payment of $500 each year, with the Class A Interest
allocated all remaining LLC income or loss.

The LLC will grant PM an exclusive license of the Marks for an 11-year term at
an annual royalty based on sales of cigarettes under the Marks, subject to a
minimum annual royalty payment equal to the annual debt service obligation on
the Loan plus $1,000.

If PM fails to exercise the Class B Option, Eve will have an option to put its
Class B Interest to PM, or PM's designees (the "Eve Put Option"), at a put price
that is $5,000 less than the exercise price of the Class B Option (and includes
PM's procuring Eve's release from its Loan guarantee). The Eve Put Option is
exercisable at any time during the 90-day period beginning March 2, 2010.

If the Class B Option, the LLC's redemption right and the Eve Put Option expire
unexercised, the holder of the Class B Interest will be entitled to convert the
Class B Interest, at its election, into a Class A Interest with the same rights
to share in future profits and losses, the same voting power and the same claim
to capital as the entire existing outstanding Class A Interest, i.e., a 50% LLC
interest.

The $150,000 in proceeds received from the sale of the Class A and B Options is
presented as a liability on the consolidated balance sheet until the closing of
the exercise of the Class A Option and the distribution of the Loan proceeds
which is scheduled to occur during the second quarter of 1999. Upon such
closing, PM will obtain control of the LLC, and the Company anticipates, based
on the expected structure of the transactions, to recognize a gain in its
consolidated financial statements to the extent of the total cash proceeds
received from the payment of the option fees, the exercise of the Class A Option
and the distribution of the Loan proceeds.


                                       8
<PAGE>   10


4.       INVENTORIES

Inventories consist of the following:

<TABLE>
<CAPTION>

                                                                        March 31,      December 31,
                                                                          1999             1998
                                                                        --------         --------

           <S>                                                          <C>              <C>
           Leaf tobacco ........................................        $  9,891         $ 10,796
           Other raw materials .................................           1,763            1,741
           Work-in-process .....................................           2,392            1,828
           Finished goods ......................................          14,235           12,231
           Replacement parts and supplies ......................           3,156            3,150
                                                                        --------         --------

           Inventories at current cost .........................          31,437           29,746

           LIFO adjustment .....................................          (3,474)          (3,772)
                                                                        --------         --------

           Inventories at LIFO cost ............................        $ 27,963         $ 25,974
                                                                        ========         ========
</TABLE>

The Company has a leaf inventory management program whereby, among other things,
it is committed to purchase certain quantities of leaf tobacco. The purchase
commitments are for quantities not in excess of anticipated requirements and are
at prices, including carrying costs, established at the date of the commitment.
Liggett had leaf tobacco purchase commitments of approximately $4,754 at March
31, 1999.


5.       PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consists of the following:

<TABLE>
<CAPTION>

                                                                        March 31,      December 31,
                                                                           1999             1998
                                                                           ----             ----

           <S>                                                          <C>              <C>
           Land and improvements ...............................        $    412         $    412
           Buildings ...........................................           5,823            5,823
           Machinery and equipment .............................          47,135           40,853
                                                                        --------         --------

           Property, plant and equipment .......................          53,370           47,088

           Less accumulated depreciation .......................         (31,663)         (30,893)
                                                                        --------         --------
           Property, plant and equipment, net ..................        $ 21,707         $ 16,195
                                                                        ========         ========
</TABLE>


                                       9


<PAGE>   11


6.       CREDIT FACILITY AND NOTE PAYABLE
<TABLE>
<CAPTION>

                                                                       March 31,     December 31,
                                                                          1999           1998
                                                                          ----           ----
          <S>                                                          <C>              <C>
          Borrowings outstanding under revolving credit
             facility .........................................        $  6,793         $2,538
          Note payable ........................................           4,475             --
                                                                       --------         ------
                                                                         11,268          2,538

          Current portion .....................................            (329)            --
                                                                       --------         ------

          Amount due after one year ...........................        $ 10,939         $2,538
                                                                       ========         ======
</TABLE>

Revolving Credit Facility:

On March 8, 1994, Liggett entered into the Facility under which it can borrow up
to $40,000 (depending on the amount of eligible inventory and receivables as
determined by the lenders) from a syndicate of commercial lenders. The Facility,
which expires March 8, 2000, is collateralized by all inventories and
receivables of the Company. Availability under the Facility was approximately
$12,990 based upon eligible collateral at March 31, 1999. Borrowings under the
Facility whose interest is calculated at a rate equal to 1.5% above Philadelphia
National Bank's prime rate bore a rate of 9.25% at March 31, 1999. The Facility
requires Liggett's compliance with certain financial and other covenants
including restrictions on the payment of cash dividends and distributions by
Liggett. In addition, the Facility, as amended April 8, 1998, imposes
requirements with respect to Liggett's permitted maximum adjusted net worth (not
to fall below a deficit of $195,000 as computed in accordance with the
agreement, this computation was $146,239 at March 31, 1999) and net working
capital (not to fall below a deficit of $17,000 as computed in accordance with
the agreement, this computation was $4,466 at March 31, 1999).

Note Payable:

In January 1999, Liggett purchased equipment for $5,750 and borrowed $4,500 to
fund the purchase from a third party. The loan, which is collateralized by the
equipment and guaranteed by BGLS and BGL, is payable in 60 monthly installments
of $56 including annual interest of 7.67% with a final payment of $2,550.


7.       COMMITMENTS AND CONTINGENCIES

TOBACCO-RELATED LITIGATION:

OVERVIEW. Since 1954, Liggett and other United States cigarette manufacturers
have been named as defendants in numerous direct and third-party actions
predicated on the theory that cigarette manufacturers should be liable for
damages from cancer and other adverse health effects alleged to have been caused
by cigarette smoking or by exposure to secondary smoke (environmental tobacco
smoke, "ETS") from cigarettes. These cases are reported hereinafter as though
having been commenced against Liggett (without regard to whether such cases were
actually commenced against Liggett or BGL). There has been a noteworthy increase
in the number of cases commenced against Liggett and the other cigarette
manufacturers in recent years. The cases generally fall into four categories:
(i) smoking and health cases alleging personal injury brought on behalf of
individual smokers ("Individual Actions"); (ii) smoking and health cases
alleging personal injury and purporting to be brought on behalf of a class of
individual plaintiffs ("Class Actions"); (iii) health care cost recovery actions
brought by various governmental entities ("Governmental Actions"); and (iv)
health care cost recovery actions brought by third-party payors



                                       10
<PAGE>   12

including insurance companies, union health and welfare trust funds, asbestos
manufacturers and others ("Third-Party Payor Actions"). As new cases are
commenced, defense costs and the risks attendant to the inherent
unpredictability of litigation continue to increase. The future financial impact
of the risks and expenses of litigation and the effects of the tobacco
litigation settlements discussed below is not quantifiable at this time. For the
three months ended March 31, 1999, Liggett incurred counsel fees and costs
totaling approximately $1,568, compared to $1,342 for the comparable prior year
period.

INDIVIDUAL ACTIONS. As of March 31, 1999, there were approximately 265 cases
pending against Liggett, and in most cases the other tobacco companies, where
individual plaintiffs allege injury resulting from cigarette smoking, addiction
to cigarette smoking or exposure to ETS and seek compensatory and, in some
cases, punitive damages. Of these, 89 were pending in Florida, 91 in New York,
29 in Massachusetts and 19 in Texas. The balance of the individual cases were
pending in 21 states. There are four individual cases pending where Liggett is
the only named defendant.

The plaintiffs' allegations of liability in those cases in which individuals
seek recovery for personal injuries allegedly caused by cigarette smoking are
based on various theories of recovery, including negligence, gross negligence,
special duty, voluntary undertaking, strict liability, fraud, misrepresentation,
design defect, failure to warn, breach of express and implied warranties,
conspiracy, aiding and abetting, concert of action, unjust enrichment, common
law public nuisance, indemnity, market share liability and violations of
deceptive trade practices laws, the Federal Racketeer Influenced and Corrupt
Organization Act ("RICO") and antitrust statutes. In many of these cases, in
addition to compensatory damages, plaintiffs also seek other forms of relief
including disgorgement of profits and punitive damages. Defenses raised by
defendants in these cases include lack of proximate cause, assumption of the
risk, comparative fault and/or contributory negligence, lack of design defect,
statute of limitations, equitable defenses such as "unclean hands" and lack of
benefit, failure to state a claim and federal preemption.

In February 1999, a state court jury in San Francisco awarded $51,500 in damages
to a woman who claimed lung cancer from smoking Marlboro cigarettes made by PM.
The award includes $1,500 in compensatory damages and $50,000 in punitive
damages. The court subsequently reduced the punitive damages award to $25,000.

In March 1999, a state court jury in Portland awarded $80,311 in damages to the
family of a deceased smoker who smoked Marlboro made by PM. The award includes
$79,500 in punitive damages.

CLASS ACTIONS. As of March 31, 1999, there were approximately 50 actions
pending, for which either a class has been certified or plaintiffs are seeking
class certification, where Liggett, among others, was a named defendant. Two of
these cases, Fletcher, et al. v. Brooke Group Ltd., et al. and Walker, et al. v.
Liggett Group Inc., et al., have been settled by the Company, subject to court
approval. These two settlements are more fully discussed below under the
"Settlements" section.

In October 1991, an action entitled Broin, et al. v. Philip Morris Incorporated,
et al., Circuit Court of the Eleventh Judicial District in and for Dade County,
Florida, was filed against Liggett and others. This case was brought by
plaintiffs on behalf of all flight attendants that worked or are presently
working for airlines based in the United States and who never regularly smoked
cigarettes but allege that they have been damaged by involuntary exposure to
ETS. In October 1997, the other major tobacco companies settled this matter,
which settlement provides for a release of Liggett and BGL. In February 1998,
the Circuit Court approved the settlement, which settlement was affirmed by the
Third District Court of Appeals in March 1999.

In March 1994, an action entitled Castano, et al. v. The American Tobacco
Company Inc., et al., United States District Court, Eastern District of
Louisiana, was filed against Liggett and others. The class action complaint
sought relief for a nationwide class of smokers based on their alleged addiction
to nicotine. In February 1995, the District Court granted plaintiffs' motion for
class certification (the "Class Certification Order").


                                       11
<PAGE>   13


In May 1996, the Court of Appeals for the Fifth Circuit reversed the Class
Certification Order and instructed the District Court to dismiss the class
complaint. The Fifth Circuit ruled that the District Court erred in its analysis
of the class certification issues by failing to consider how variations in state
law affect predominance of common questions and the superiority of the class
action mechanism. The appeals panel also held that the District Court's
predominance inquiry did not include consideration of how a trial on the merits
in Castano would be conducted. The Fifth Circuit further ruled that the
"addiction-as-injury" tort is immature and, accordingly, the District Court
could not know whether common issues would be a "significant" portion of the
individual trials. According to the Fifth Circuit's decision, any savings in
judicial resources that class certification may bring about were speculative and
would likely be overwhelmed by the procedural problems certification brings.
Finally, the Fifth Circuit held that in order to make the class action
manageable, the District Court would be forced to bifurcate issues in violation
of the Seventh Amendment.

The extent of the impact of the Castano decision on tobacco-related class action
litigation is still uncertain, although the decertification of the Castano class
by the Fifth Circuit may preclude other federal courts from certifying a
nationwide class action for trial purposes with respect to tobacco-related
claims. The Castano decision has had to date, however, only limited effect with
respect to courts' decisions regarding narrower tobacco-related classes or class
actions brought in state rather than federal court. For example, since the Fifth
Circuit's ruling, courts in New York, Louisiana and Maryland have certified
"addiction-as-injury" class actions that covered only citizens in those states.
Two class actions pending in state court in Florida have also been certified,
one of which, the Broin case, was settled in 1997. The Castano decision has had
no measurable impact on litigation brought by or on behalf of single individual
claimants.

Class certification motions are pending in a number of putative class actions.
Class certification has been denied or reversed in 13 actions while classes
remain certified in two cases in Florida and Maryland. A number of class
certification decisions are on appeal.

GOVERNMENTAL ACTIONS. As of March 31, 1999, there were approximately 20
Governmental Actions pending against Liggett. In these proceedings, the
governmental entities seek reimbursement for Medicaid and other health care
expenditures allegedly caused by use of tobacco products. The claims asserted in
these health care cost recovery actions vary. In most of these cases, plaintiffs
assert the equitable claim that the tobacco industry was "unjustly enriched" by
plaintiffs' payment of health care costs allegedly attributable to smoking and
seek reimbursement of those costs. Other claims made by some but not all
plaintiffs include the equitable claim of indemnity, common law claims of
negligence, strict liability, breach of express and implied warranty, violation
of a voluntary undertaking or special duty, fraud, negligent misrepresentation,
conspiracy, public nuisance, claims under state and federal statutes governing
consumer fraud, antitrust, deceptive trade practices and false advertising, and
claims under RICO.

On January 19, 1999, at the State of the Union Address, President Clinton
announced that the Department of Justice ("DOJ") was preparing a litigation plan
to take the tobacco industry to court to recover monies that Medicare and other
programs allegedly expended to treat smoking-related illnesses. The effects of
this lawsuit cannot be predicted at this time; however, an adverse verdict could
have a material adverse effect on the Company and Liggett.

THIRD-PARTY PAYOR ACTIONS. As of March 31, 1999, there were approximately 70
Third-Party Payor Actions pending against Liggett. The claims in these cases are
similar to those in the Governmental Actions but have been commenced by
insurance companies, union health and welfare trust funds, asbestos
manufacturers and others. In April 1998, a group known as the "Coalition for
Tobacco Responsibility", which represents Blue Cross and Blue Shield Plans in
more than 35 states, filed federal lawsuits against the industry seeking payment
of health-care costs allegedly incurred as a result of cigarette smoking and
ETS. The lawsuits were filed in Federal District Courts in New York, Chicago,
and Seattle and seek billions of dollars in damages. The lawsuits allege
conspiracy, fraud, misrepresentation and violation of federal racketeering and
antitrust laws as well as other claims. In January 1999, a federal judge in
Seattle


                                       12
<PAGE>   14

dismissed a Third-Party Payor Action brought by seven Blue Cross/Blue Shield
Plans against the tobacco industry. The court ruled that the insurance providers
did not have standing to bring the lawsuit. However, in February 1999, a federal
judge in the Eastern District of New York denied pleas by the industry to
dismiss the Third-Party Payor Action brought by 24 Blue Cross/Blue Shield Plans.

In other Third-Party Payor Actions, claimants have set forth several additional
theories of relief sought: funding of corrective public education campaigns
relating to issues of smoking and health; funding for clinical smoking cessation
programs; disgorgement of profits from sales of cigarettes; restitution; treble
damages; and attorneys' fees. Nevertheless, no specific amounts are provided. It
is understood that requested damages against the tobacco company defendants in
these cases might be in the billions of dollars.

SETTLEMENTS. In March 1996, Liggett and BGL entered into an agreement, subject
to court approval, to settle the Castano class action tobacco litigation. Under
the Castano settlement agreement, upon final court approval of the settlement,
the Castano class would be entitled to receive up to five percent of Liggett's
pretax income (income before income taxes) each year (up to a maximum of $50,000
per year) for the next 25 years, subject to certain reductions provided for in
the agreement and a $5,000 payment from Liggett if Liggett or BGL fail to
consummate a merger or similar transaction with another non-settling tobacco
company defendant within three years of the date of settlement. Liggett and BGL
have the right to terminate the Castano settlement under certain circumstances.
In March, 1996, Liggett, the Castano Plaintiffs Legal Committee and the Castano
plaintiffs entered into a letter agreement. According to the terms of the letter
agreement, for the period ending nine months from the date of Final Approval (as
defined in the letter), if granted, of the Castano settlement or, if earlier,
the completion by Liggett or BGL of a combination with any defendant in Castano,
except PM, the Castano plaintiffs and their counsel agree not to enter into any
more favorable settlement agreement with any Castano defendant which would
reduce the terms of the Castano settlement agreement. If the Castano plaintiffs
or their counsel enter into any such settlement during this period, they shall
pay Liggett $250,000 within 30 days of the more favorable agreement and offer
Liggett and BGL the option to enter into a settlement on terms at least as
favorable as those included in such other settlement. The letter agreement
further provides that during the same time period, and if the Castano settlement
agreement has not been earlier terminated by Liggett in accordance with its
terms, Liggett and its affiliates will not enter into any business transaction
with any third party which would cause the termination of the Castano settlement
agreement. If Liggett or its affiliates enter into any such transaction, then
the Castano plaintiffs will be entitled to receive $250,000 within 30 days from
the transacting party. In May 1996, the Castano Plaintiffs Legal Committee filed
a motion with the United States District Court for the Eastern District of
Louisiana seeking preliminary approval of the Castano settlement. In September
1996, shortly after the class was decertified, the Castano plaintiffs withdrew
the motion for approval of the Castano settlement.

In March 1996, March 1997 and March 1998, Liggett and BGL entered into
settlements of tobacco-related litigation with the Attorneys General of a total
of 45 states and territories. The settlements released Liggett and BGL from all
tobacco-related claims including claims for health care cost reimbursement and
claims concerning sales of cigarettes to minors.

On November 23, 1998, PM, B&W, R.J. Reynolds Tobacco Company ("RJR") and
Lorillard Tobacco Company ("Lorillard") (collectively, the "Original
Participating Manufacturers" or "OPMs") and Liggett (together with the OPMs and
any other tobacco product manufacturer that becomes a signatory, the
"Participating Manufacturers") entered into the Master Settlement Agreement (the
"MSA") with 46 states, the District of Columbia, Puerto Rico, Guam, the United
States Virgin Islands, American Samoa and the Northern Marianas (collectively,
the "Settling States") to settle the asserted and unasserted health care cost
recovery and certain other claims of those Settling States. As described below,
Liggett and BGL had previous settlements with a number of these Settling States
and also had previously settled similar claims brought by Florida, Mississippi,
Texas and Minnesota.

                                       13
<PAGE>   15

The MSA is subject to final judicial approval in each of the Settling States,
which approval has been obtained, to date, in 42 states and territories.

The MSA restricts tobacco product advertising and marketing within the Settling
States and otherwise restricts the activities of Participating Manufacturers.
Among other things, the MSA: prohibits the targeting of youth in the
advertising, promotion or marketing of tobacco products; bans the use of cartoon
characters in all tobacco advertising and promotion; limits each Participating
Manufacturer to one tobacco brand name sponsorship during any 12-month period;
bans all outdoor advertising, with the exception of signs 14 square feet or less
in dimension at retail establishments that sell tobacco products; prohibits
payments for tobacco product placement in various media; bans gift offers based
on the purchase of tobacco products without sufficient proof that the intended
recipient is an adult; prohibits Participating Manufacturers from licensing
third parties to advertise tobacco brand names in any manner prohibited under
the MSA; prohibits Participating Manufacturers from using as a tobacco product
brand name any nationally recognized non-tobacco brand or trade name or the
names of sports teams, entertainment groups or individual celebrities; and
prohibits Participating Manufacturers from selling packs containing fewer than
twenty cigarettes.

The MSA also requires Participating Manufacturers to affirm corporate principles
to comply with the MSA and to reduce underage usage of tobacco products and
imposes requirements applicable to lobbying activities conducted on behalf of
Participating Manufacturers.

Pursuant to the MSA, Liggett has no payment obligations unless its market share
exceeds 125% of its 1997 market share (the "Base Share"). In the year following
any year in which Liggett's market share does exceed the Base Share, Liggett
will pay on each excess unit an amount equal (on a per-unit basis) to that paid
during such following year by the OPMs pursuant to the annual and strategic
contribution payment provisions of the MSA, subject to applicable adjustments,
offsets and reductions. Pursuant to the annual and strategic contribution
payment provisions of the MSA, the OPMs (and Liggett to the extent its market
share exceeds the Base Share) will pay the following annual amounts (subject to
certain adjustments):

<TABLE>
<CAPTION>

                          Year                    Amount
                          ----                    ------
              
                  <S>                           <C>
                  2000                          $4,500,000
                  2001                          $5,000,000
                  2002 - 2003                   $6,500,000
                  2004 - 2007                   $8,000,000
                  2008 - 2017                   $8,139,000
                  2018 and each                 $9,000,000
                       year thereafter
</TABLE>


These annual payments will be allocated based on relative unit volume of
domestic cigarette shipments. The payment obligations under the MSA are the
several, and not joint, obligations of each Participating Manufacturer and are
not the responsibility of any parent or affiliate of a Participating
Manufacturer.

The MSA replaces Liggett's prior settlements with all states and territories
except for Florida, Mississippi, Texas and Minnesota. In the event the MSA does
not receive final judicial approval in any state or territory, Liggett's prior
settlement with that state or territory, if any, will be revived.

The states of Florida, Mississippi, Texas and Minnesota, prior to the effective
date of the MSA, negotiated and executed settlement agreements with each of the
other major tobacco companies separate from those settlements reached previously
with Liggett. Because these states' settlement agreements with Liggett provided
for "most favored nations" protection for both Liggett and BGL, the payments due
these states by Liggett (with certain possible exceptions) have been eliminated.
With respect to all non-economic


                                       14
<PAGE>   16
obligations under the previous settlements, both Liggett and BGL are entitled to
the most favorable provisions as between the MSA and each state's respective
settlement with the other major tobacco companies. Therefore, Liggett's
non-economic obligations to all states and territories are now defined by the
MSA.

In March 1997, Liggett, BGL and a nationwide class of individuals that allege
smoking-related claims filed a mandatory class settlement agreement in an action
entitled Fletcher, et al. v. Brooke Group Ltd., et al., Circuit Court of Mobile
County, Alabama, where the court granted preliminary approval and preliminary
certification of the class, and in May 1997, a similar mandatory class
settlement agreement was filed in an action entitled Walker, et al. v. Liggett
Group Inc., et al., United States District Court, Southern District of West
Virginia. In July, 1998, Liggett, BGL and plaintiffs filed an amended class
action settlement agreement in Fletcher which agreement was preliminarily
approved by the court in December, 1998. A hearing on final approval of the
settlement is scheduled for June 3, 1999; however, hearing dates are subject to
change. Effectiveness of the mandatory settlement is conditioned on final court
approval of the settlement. There can be no assurance as to whether, or when,
such court approval will be obtained. Pursuant to the amended agreement, Liggett
is required to pay to the class 7.5% of Liggett's pre-tax income each year for
25 years, with a minimum annual payment guarantee of $1,000 over the term of the
agreement. The amended agreement does not set forth a formula with respect to
the distribution of settlement proceeds to the class. If the court issues a
final order and judgment approving the settlement, such an order, Liggett
anticipates, would preclude further prosecution by class members of
tobacco-related claims against both Liggett and BGL. Under the Full Faith and
Credit Act, a final judgment entered in a nationwide class action pending in a
state court has a preclusive effect against any class member with respect to the
claims settled and released. As the class definition in Fletcher encompasses all
persons in the United States who could claim injury as a result of cigarette
smoking or ETS and any third-party payor claimants, it is anticipated that, upon
final order and judgment, all such persons and third-party payor claimants would
be barred from further prosecution of tobacco-related claims against Liggett and
BGL.

The Walker court also granted preliminary approval and preliminary certification
of the nationwide class; however, in August 1997, the court vacated its
preliminary certification of the settlement class, which decision is currently
on appeal. The Walker court relied on the Supreme Court's decision in Amchem
Products Inc. v. Windsor in reaching its decision to vacate preliminary
certification of the class. In Amchem, the Supreme Court affirmed a decision of
the Third Circuit vacating the certification of a settlement class that involved
asbestos-exposure claims. The Supreme Court held that the proposed settlement
class did not meet the requirements of Rule 23 of the Federal Rules of Civil
Procedure for predominance of common issues and adequacy of representation. The
Third Circuit had held that, although classes could be certified for settlement
purposes, Rule 23's requirements had to be satisfied as if the case were going
to be litigated. The Supreme Court agreed that the fairness and adequacy of the
settlement are not pertinent to the predominance inquiry under Rule 23(b)(3),
and thus, the proposed class must have sufficient unity so that absent class
members can fairly be bound by decisions of class representatives.

After the Amchem opinion was issued by the Supreme Court in June 1997, objectors
to Liggett's settlement in Walker moved for decertification. Although Liggett's
settlement in the Walker action is a "limited fund" class action settlement
proceeding under Rule 23(b)(1) and Amchem was a Rule 23 (b)(3) case, the court
in the Walker action, nonetheless, decertified the Walker class. Applying Amchem
to the Walker case, the District Court, in a decision issued in August 1997,
determined that while plaintiffs in Walker have a common interest in "maximizing
the limited fund available from the defendants," there remained "substantial
conflicts among class members relating to distribution of the fund and other key
concerns" that made class certification inappropriate.

The Amchem decision's ultimate affect on the viability of both the Walker and
Fletcher settlements remains uncertain given the Fifth Circuit's recent ruling
reaffirming a limited fund class action settlement in In re Asbestos Litigation
("Ahearn"). In June 1997, the Supreme Court remanded Ahearn to the Fifth Circuit
for consideration in light of Amchem. On remand, the Fifth Circuit made two
decisive distinctions


                                       15
<PAGE>   17


between Amchem and Ahearn. First, the Ahearn class action proceeded under Rule
23(b)(1) while Amchem was a Rule 23(b)(3) case, and second, in Ahearn, there was
no allocation or difference in award, according to nature or severity of injury,
as there was in Amchem. The Fifth Circuit concluded that all members of the
class and all class representatives share common interests and none of the
uncommon questions abounding in Amchem exist. In June, 1998, the Supreme Court
granted certiorari to review the Fifth Circuit decision.

Liggett previously accrued approximately $4,000 for the present value of the
fixed payments under the March 1996 Attorneys General settlements and $16,902
for the present value of the fixed payments under the March 1998 Attorneys
General settlements. As a result of Liggett's treatment under the MSA, $14,928
of net charges accrued for the prior settlements were reversed in 1998.

Copies of the various settlement agreements are filed as exhibits to BGL's Form
10-K and the discussion herein is qualified in its entirety by reference
thereto.

TRIALS. In July 1998, trial commenced in the Engle, et al. v. Philip Morris
Incorporated, et al., case, a class action pending in Miami Dade County,
Florida, brought on behalf of all Florida residents allegedly injured by
smoking. Plaintiffs seek compensatory and punitive damages ranging into the
billions of dollars, as well as equitable relief including, but not limited to,
a medical fund for future health care costs, attorneys' fees and court costs.
The class consists of all Florida residents and citizens, and their survivors,
who claim to have suffered, presently suffer or have died from diseases and
medical conditions caused by their addiction to cigarettes that contain
nicotine.

The current trial plan calls for the case to be tried in three "Phases". Phase
One, which is currently underway, involves evidence concerning certain "common"
class issues relating to the plaintiff class' causes of action. Entitlement to
punitive damages will be decided at the end of Phase One, but no amount will be
set at that time.

If plaintiffs prevail in Phase One, the first two stages of Phase Two will
involve individual determinations of specific causation and other individual
issues regarding entitlement to compensatory damages for the class
representatives. Stage three of Phase Two will involve an assessment of the
amount of punitive damages, if any, that individual class representatives will
be awarded. Stage four of Phase Two will involve the setting of a percentage or
ratio of punitive damages for absent class members, assuming entitlement was
found at the end of Phase One.

Phase Three of the trial will be held before separate juries to address absent
class members' claims, including issues of specific causation and other
individual issues regarding entitlement to compensatory damages.

Additional cases are currently scheduled for trial during 1999, including two
Third-Party Payor Actions brought by unions in Washington (September) and New
York (September), and three Class Actions in Alabama (August), Wisconsin
(September) and New York (November). Also, six Individual Actions are currently
scheduled for trial during 1999. Trial dates, however, are subject to change.

OTHER RELATED MATTERS. A grand jury investigation is being conducted by the
office of the United States Attorney for the Eastern District of New York (the
"Eastern District Investigation") regarding possible violations of criminal law
relating to the activities of The Council for Tobacco Research - USA, Inc. (the
"CTR"). Liggett was a sponsor of the CTR at one time. In May 1996, Liggett
received a subpoena from a Federal grand jury sitting in the Eastern District of
New York, to which Liggett has responded.

In March 1996, and in each of March, July, October and December 1997, Liggett
and/or BGL received subpoenas from a Federal grand jury in connection with an
investigation by the United States Department of Justice (the "DOJ
Investigation") involving the industry's knowledge of: the health consequences
of

                                       16
<PAGE>   18

smoking cigarettes; the targeting of children by the industry; and the
addictive nature of nicotine and the manipulation of nicotine by the industry.
Liggett has responded to the March 1996, March 1997 and July 1997 subpoenas and
is in the process of responding to the October and December 1997 subpoenas The
Company understands that the Eastern District Investigation and the DOJ
Investigation essentially have been consolidated into one investigation
conducted by the DOJ. Liggett and BGL are unable, at this time, to predict the
outcome of this investigation.

In April 1998, BGL announced that Liggett had reached an agreement with the DOJ
to cooperate in both the Eastern District Investigation and the DOJ
Investigation. The agreement does not constitute an admission of any wrongful
behavior by Liggett. The DOJ has not provided immunity to Liggett and has full
discretion to act or refrain from acting with respect to Liggett in the
investigation.

In September 1998, Liggett received a subpoena from a federal grand jury in the
Eastern District of Philadelphia investigating possible antitrust violations in
connection with the purchase of tobacco by and for tobacco companies. Liggett
has responded to this subpoena. Liggett and BGL are unable, at this time, to
predict the outcome of this investigation.

Litigation is subject to many uncertainties, and it is possible that some of the
aforementioned actions could be decided unfavorably against Liggett or BGL. An
unfavorable outcome of a pending smoking and health case could encourage the
commencement of additional similar litigation. Liggett is unable to make a
meaningful estimate with respect to the amount of loss that could result from an
unfavorable outcome of many of the cases pending against the Company, because
the complaints filed in these cases rarely detail alleged damages. Typically,
the claims set forth in an individual's complaint against the tobacco industry
pray for money damages in an amount to be determined by a jury, plus punitive
damages and costs. These damage claims are typically stated as being for the
minimum necessary to invoke the jurisdiction of the court.

It is possible that Liggett's consolidated financial position, results of
operations or cash flow could be materially adversely affected by an unfavorable
outcome in any such tobacco-related litigation.

Liggett has been involved in certain environmental proceedings, none of which,
either individually or in the aggregate, rises to the level of materiality.
Liggett's management believes that current operations are conducted in material
compliance with all environmental laws and regulations. Management is unaware of
any material environmental conditions affecting its existing facilities.
Compliance with federal, state and local provisions regulating the discharge of
materials into the environment, or otherwise relating to the protection of the
environment, has not had a material effect on the capital expenditures, earnings
or competitive position of Liggett.

There are several other proceedings, lawsuits and claims pending against Liggett
unrelated to smoking or tobacco product liability. Management is of the opinion
that the liabilities, if any, ultimately resulting from such other proceedings,
lawsuits and claims should not materially affect Liggett's financial position,
results of operations or cash flows.

LEGISLATION AND REGULATION:

In 1993, the United States Environmental Protection Agency ("EPA") released a
report on the respiratory effect of ETS which concludes that ETS is a known
human lung carcinogen in adults and in children, causes increased respiratory
tract disease and middle ear disorders and increases the severity and frequency
of asthma. In June 1993, the two largest of the major domestic cigarette
manufacturers, together with other segments of the tobacco and distribution
industries, commenced a lawsuit against the EPA seeking a determination that the
EPA did not have the statutory authority to regulate ETS, and that given the
current body of scientific evidence and the EPA's failure to follow its own
guidelines in making the determination, the EPA's classification of ETS was
arbitrary and capricious. Whatever the outcome of this litigation, issuance of
the report may encourage efforts to limit smoking in public areas. In July 1998,
the court ruled


                                       17
<PAGE>   19

that the EPA made procedural and scientific mistakes when it declared in its
1993 report that secondhand smoke caused as many as 3,000 cancer deaths a year
among nonsmokers.

In February 1996, the United States Trade representative issued an "advance
notice of rule making" concerning how tobaccos imported under a previously
established tobacco rate quota ("TRQ") should be allocated. Currently, tobacco
imported under the TRQ is allocated on a "first-come, first-served" basis,
meaning that entry is allowed on an open basis to those first requesting entry
in the quota year. Others in the cigarette industry have suggested an "end-user
licensing" system under which the right to import tobacco under the quota would
be initially assigned based on domestic market share. Such an approach, if
adopted, could have a material adverse effect on Liggett and BGL.

In August 1996, the FDA filed in the Federal Register a Final Rule (the "FDA
Rule") classifying tobacco as a drug, asserting jurisdiction by the FDA over the
manufacture and marketing of tobacco products and imposing restrictions on the
sale, advertising and promotion of tobacco products. Litigation was commenced in
the United States District Court for the Middle District of North Carolina
challenging the legal authority of the FDA to assert such jurisdiction, as well
as challenging the constitutionality of the rules. The court, after argument,
granted plaintiffs' motion for summary judgment prohibiting the FDA from
regulating or restricting the promotion and advertising of tobacco products and
denied plaintiffs' motion for summary judgment on the issue of whether the FDA
has the authority to regulate access to, and labeling of, tobacco products. The
Fourth Circuit reversed the district court on appeal and in August 1998 held
that the FDA cannot regulate tobacco products because Congress had not given
them the authority to do so. Liggett and BGL support the FDA Rule and have begun
to phase in compliance with certain of the proposed interim FDA regulations. See
discussions of the Castano and Governmental Actions settlements above. See also
"Subsequent Events" below.

In August 1996, Massachusetts enacted legislation requiring tobacco companies to
publish information regarding the ingredients in cigarettes and other tobacco
products sold in that state. In December 1997, the United States District Court
for the District of Massachusetts enjoined this legislation from going into
effect; however, in December 1997, Liggett began complying with this legislation
by providing ingredient information to the Massachusetts Department of Public
Health. Several other states have enacted, or are considering, legislation
similar to that enacted in Massachusetts.

As part of the 1997 budget agreement approved by Congress, federal excise taxes
on a pack of cigarettes, which are currently 24 cents, would rise 10 cents in
the year 2000 and 5 cents more in the year 2002. Additionally, in November 1998,
the citizens of California voted in favor of a 50 cents per pack tax on
cigarettes sold in that state.

In addition to the foregoing, there have been a number of other restrictive
regulatory actions, adverse political decisions and other unfavorable
developments concerning cigarette smoking and the tobacco industry, the effects
of which, at this time, Liggett is not able to evaluate.

SUBSEQUENT EVENTS: In April 1999, the Supreme Court granted certiorari to review
the Fourth Circuit's decision that the FDA does not have the authority to
regulate access to, and labeling of, tobacco products.

YEAR 2000 COSTS:

Liggett utilizes management information systems and software technology that may
be affected by Year 2000 issues throughout its operations. The Company has
evaluated the costs to implement century date change compliant systems
conversions and is in the process of executing a planned conversion of its
systems prior to the Year 2000. To date, the focus of Year 2000 compliance and
verification efforts has been directed at the implementation of new customer
service, inventory control and financial reporting systems at each of the three
regional Strategic Business Units, part of the Company's reorganization which
began in January 1997. Liggett estimates that approximately $138 of the
expenditures related to this


                                       18
<PAGE>   20

reengineering effort related to Year 2000 compliance, validation and testing. In
January of 1998, Liggett initiated a major conversion of factory accounting,
materials management and information systems at its Durham production facility
with upgrades that have been successfully tested for Year 2000 compliance. This
conversion was completed in November 1998. Program upgrades to Liggett's human
resources and payroll systems, budgeted at $160, are scheduled for completion in
July of 1999. Enhancements to the Company's finished goods inventory system are
expected to be completed in September 1999. It is anticipated that all factory,
corporate, field sales and physical distribution systems will be completed in
sufficient time to support Year 2000 compliance and verification.

Although such costs may be a factor in describing changes in operating profit in
any given reporting period, the Company currently does not believe that the
anticipated costs of Year 2000 systems conversions will have a material impact
on its future consolidated results of operations. Based on the progress Liggett
has made in addressing Year 2000 issues and its strategy and timetable to
complete its compliance program, the Company does not foresee significant risks
associated with its Year 2000 initiatives at this time. Although the Company is
in the process of confirming that service providers are adequately addressing
Year 2000 issues, there can be no complete assurance of success, or that
interaction with other service providers will not impair the Company's service.


8.       RELATED PARTY TRANSACTIONS

Liggett is party to a Tax-Sharing Agreement dated June 29, 1990 with BGL and
certain other entities pursuant to which Liggett has paid taxes to BGL as if it
were filing a separate company tax return, except that the agreement effectively
limits the ability of Liggett to carry back losses for refunds. Liggett is
entitled to recoup overpayments in a given year out of future payments due under
the agreement.

Liggett is a party to an agreement dated February 26, 1991, as amended October
1, 1995, with BGL to provide various management and administrative services to
the Company in consideration for an annual management fee of $900 paid in
monthly installments and annual overhead reimbursements of $864 paid in
quarterly installments.

In addition, Liggett has entered into an annually renewable Corporate Services
Agreement with BGLS wherein BGLS agreed to provide corporate services to the
Company at an annual fee paid in monthly installments. Corporate services
provided by BGLS under this agreement include the provision of administrative
services related to Liggett's participation in its parent company's
multi-employer benefit plan, external publication of financial results,
preparation of consolidated financial statements and tax returns and such other
administrative and managerial services as may be reasonably requested by
Liggett. The charges for services rendered under the agreement amounted to $915
in the first quarter of 1999 and $1,020 in the first quarter of 1998.

The Company leases equipment from a subsidiary of BGLS for $50 per month.



                                       19